MEDRAD is a market leader in computed tomography, magnetic resonance imaging, and interventional cardiology. Every day, MEDRAD products help to reveal possibilities for thousands of physicians and their patients.Our performance is a result of unrelenting commitment to improving healthcare, to upholding standards of excellence, and to responsible activities for the benefit of our customers, shareholders, employees, and communities. Our promise to deliver unequaled reliability and trust in our products, people, and services can be summed up in a simple, yet powerful phrase – Performance. For life.MEDRAD, Inc. develops, markets and services medical devices used to diagnose and treat disease. Its product offerings include fluid injection systems for radiology and cardiology, endovascular devices for the safe treatment of cardiovascular disease, magnetic resonance-compatible accessories and equipment services. MEDRAD is a business of Bayer Healthcare.